A1C: Episode 2

Overview

Journal Clin Diabetes

Specialty Endocrinology

Date 2024 May 2

PMID 38694251

Authors

Nay Linn Aung

Affiliations

Soon will be listed here.

Citing Articles

Postprandial Plasma Glucose.

Aung N Clin Diabetes. 2025; 43(1):161-164.

PMID: 39829699 PMC: 11739343. DOI: 10.2337/cd24-0099.

Plasma Glucose.

Aung N Clin Diabetes. 2024; 42(4):574-578.

PMID: 39429450 PMC: 11486848. DOI: 10.2337/cd24-0074.

A1C: Episode 3.

Aung N Clin Diabetes. 2024; 42(3):448-451.

PMID: 39015166 PMC: 11247035. DOI: 10.2337/cd24-0038.

References

Carlsen S, Skrivarhaug T, Thue G, Cooper J, Goransson L, Lovaas K . Glycemic control and complications in patients with type 1 diabetes - a registry-based longitudinal study of adolescents and young adults. Pediatr Diabetes. 2016; 18(3):188-195. DOI: 10.1111/pedi.12372. View

. International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care. 2009; 32(7):1327-34. PMC: 2699715. DOI: 10.2337/dc09-9033. View

Guerin A, Nisenbaum R, Ray J . Use of maternal GHb concentration to estimate the risk of congenital anomalies in the offspring of women with prepregnancy diabetes. Diabetes Care. 2007; 30(7):1920-5. DOI: 10.2337/dc07-0278. View

Bjornstad P, Drews K, Caprio S, Gubitosi-Klug R, Nathan D, Tesfaldet B . Long-Term Complications in Youth-Onset Type 2 Diabetes. N Engl J Med. 2021; 385(5):416-426. PMC: 8697255. DOI: 10.1056/NEJMoa2100165. View

Samuelsson U, Steineck I, Gubbjornsdottir S . A high mean-HbA1c value 3-15 months after diagnosis of type 1 diabetes in childhood is related to metabolic control, macroalbuminuria, and retinopathy in early adulthood--a pilot study using two nation-wide population based quality registries. Pediatr Diabetes. 2013; 15(3):229-35. DOI: 10.1111/pedi.12085. View

Maahs D, Hermann J, DuBose S, Miller K, Heidtmann B, DiMeglio L . Contrasting the clinical care and outcomes of 2,622 children with type 1 diabetes less than 6 years of age in the United States T1D Exchange and German/Austrian DPV registries. Diabetologia. 2014; 57(8):1578-85. DOI: 10.1007/s00125-014-3272-2. View

. Safety and tolerability of the treatment of youth-onset type 2 diabetes: the TODAY experience. Diabetes Care. 2013; 36(6):1765-71. PMC: 3661822. DOI: 10.2337/dc12-2390. View

Leiter L, Boras D, Woo V . Dosing irregularities and self-treated hypoglycemia in type 2 diabetes: results from the Canadian cohort of an international survey of patients and healthcare professionals. Can J Diabetes. 2014; 38(1):38-44. DOI: 10.1016/j.jcjd.2013.08.270. View

Huang E, Zhang Q, Gandra N, Chin M, Meltzer D . The effect of comorbid illness and functional status on the expected benefits of intensive glucose control in older patients with type 2 diabetes: a decision analysis. Ann Intern Med. 2008; 149(1):11-9. PMC: 2562733. DOI: 10.7326/0003-4819-149-1-200807010-00005. View

10.

Nielsen G, Moller M, Sorensen H . HbA1c in early diabetic pregnancy and pregnancy outcomes: a Danish population-based cohort study of 573 pregnancies in women with type 1 diabetes. Diabetes Care. 2006; 29(12):2612-6. DOI: 10.2337/dc06-0914. View

11.

. Retinopathy in youth with type 2 diabetes participating in the TODAY clinical trial. Diabetes Care. 2013; 36(6):1772-4. PMC: 3661825. DOI: 10.2337/dc12-2387. View

12.

Swift P, Skinner T, de Beaufort C, Cameron F, Aman J, Aanstoot H . Target setting in intensive insulin management is associated with metabolic control: the Hvidoere childhood diabetes study group centre differences study 2005. Pediatr Diabetes. 2009; 11(4):271-8. DOI: 10.1111/j.1399-5448.2009.00596.x. View

13.

Aung N . A1C: Episode 1. Clin Diabetes. 2024; 42(1):165-168. PMC: 10788652. DOI: 10.2337/cd23-0084. View

14.

. Effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus: Diabetes Control and Complications Trial. Diabetes Control and Complications Trial Research.... J Pediatr. 1994; 125(2):177-88. DOI: 10.1016/s0022-3476(94)70190-3. View

15.

Lachin J, Genuth S, Cleary P, Davis M, Nathan D . Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. N Engl J Med. 2000; 342(6):381-9. PMC: 2630213. DOI: 10.1056/NEJM200002103420603. View

16.

Nathan D, Genuth S, Lachin J, Cleary P, Crofford O, Davis M . The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993; 329(14):977-86. DOI: 10.1056/NEJM199309303291401. View

17.

McCoy R, Van Houten H, Ziegenfuss J, Shah N, Wermers R, Smith S . Self-report of hypoglycemia and health-related quality of life in patients with type 1 and type 2 diabetes. Endocr Pract. 2013; 19(5):792-9. DOI: 10.4158/EP12382.OR. View

18.

Lachin J, White N, Hainsworth D, Sun W, Cleary P, Nathan D . Effect of intensive diabetes therapy on the progression of diabetic retinopathy in patients with type 1 diabetes: 18 years of follow-up in the DCCT/EDIC. Diabetes. 2014; 64(2):631-42. PMC: 4303965. DOI: 10.2337/db14-0930. View

19.

Jensen D, Korsholm L, Ovesen P, Beck-Nielsen H, Moelsted-Pedersen L, Westergaard J . Peri-conceptional A1C and risk of serious adverse pregnancy outcome in 933 women with type 1 diabetes. Diabetes Care. 2009; 32(6):1046-8. PMC: 2681038. DOI: 10.2337/dc08-2061. View

20.

Combs C, GUNDERSON E, KITZMILLER J, Gavin L, Main E . Relationship of fetal macrosomia to maternal postprandial glucose control during pregnancy. Diabetes Care. 1992; 15(10):1251-7. DOI: 10.2337/diacare.15.10.1251. View